Wellington Management Group LLP Takes $111,000 Position in Cibus, Inc. (NASDAQ:CBUS)

Wellington Management Group LLP acquired a new stake in Cibus, Inc. (NASDAQ:CBUS) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 33,962 shares of the company’s stock, valued at approximately $111,000. Wellington Management Group LLP owned about 0.13% of Cibus at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. SG Americas Securities LLC acquired a new position in Cibus during the third quarter valued at approximately $33,000. HighTower Advisors LLC boosted its holdings in shares of Cibus by 20.6% during the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after buying an additional 2,750 shares during the period. Swan Global Investments LLC acquired a new position in Cibus in the 3rd quarter valued at $115,000. Charles Schwab Investment Management Inc. raised its holdings in Cibus by 14.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock worth $161,000 after acquiring an additional 6,276 shares during the period. Finally, FineMark National Bank & Trust lifted its position in Cibus by 24.3% during the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after acquiring an additional 4,000 shares during the last quarter. 33.81% of the stock is currently owned by institutional investors.

Cibus Price Performance

NASDAQ CBUS opened at $2.64 on Friday. The company’s fifty day moving average is $4.16 and its two-hundred day moving average is $6.24. The firm has a market capitalization of $69.84 million, a price-to-earnings ratio of -0.12 and a beta of 1.86. Cibus, Inc. has a 52-week low of $2.37 and a 52-week high of $23.18.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $20.00 price target on shares of Cibus in a research report on Tuesday, October 22nd. Alliance Global Partners decreased their target price on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research note on Tuesday, September 24th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $25.00 price target on shares of Cibus in a research report on Monday, November 11th.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.